Participating in Oxford Lane Capital Corp.'s (OXLC) non-transferable rights offering a year ago was a slam-dunk decision for many shareholders, but this year's offering is not so obviously enticing. Last year's offering featured:
· Exercise price of $14.50 versus a market price in the range of $15 to $16.
· Net asset value that was even higher than the market price, so the rights offering represented a "discount on a discount" to potential OXLC buyers.
· Even investors who didn't own OXLC had plenty of time to buy in and get the discounted price, since the exercise price was announced 11 days before the record date.
This would have been too good an opportunity to miss,...
Only subscribers can access this article, which is part of the PRO research library covering 3,556 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: